Evidence map›Paper›PMID 28692701›Full record

ArticlePloS one2017

Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014.

Rocío Arellano-Llamas, Luis Alfaro-Ruiz, Cristian Arriaga Canon, Ivan Imaz Rosshandler, Alfredo Cruz-Lagunas, Joaquín Zúñiga, Rosa Rebollar Vega, Christopher W Wong, Sebastian Maurer-Stroh, Sandra Romero Córdoba and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Host-Driven Genetic Diversity ofTransboundary and emerging diseases · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Rocío Arellano-LlamasInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Luis Alfaro-RuizInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Cristian Arriaga CanonCONACYT- Instituto Nacional de Cancerología, Mexico City, Mexico.
Ivan Imaz RosshandlerInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Alfredo Cruz-LagunasInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Joaquín ZúñigaInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
Rosa Rebollar VegaInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Christopher W WongGenome Insitute of Singapore, Singapore, Singapore.
Sebastian Maurer-StrohBioinformatics Institute of Singapore, Singapore, Singapore.
Sandra Romero CórdobaInstituto Nacional de Medicina Genómica, Mexico City, Mexico.
Edison T LiuThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Alfredo Hidalgo-MirandaInstituto Nacional de Medicina Genómica, Mexico City, Mexico.ORCID http://orcid.org/0000-0003-2315-3977
Joel A Vázquez-PérezInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
National Institute of Genomic Medicine · MXInstituto Nacional de Enfermedades Respiratorias · MXBioinformatics Institute · SGGenome Institute of Singapore · SGInstituto Nacional de Cancerología · MXJackson Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the emergence of the pandemic H1N1pdm09 virus in Mexico and California, biannual increases in the number of cases have been detected in Mexico. As observed in previous seasons, pandemic A/H1N1 09 virus was detected in severe cases during the 2011-2012 winter season and finally, during the 2013-2014 winter season it became the most prevalent influenza virus. Molecular and phylogenetic analyses of the whole viral genome are necessary to determine the antigenic and pathogenic characteristics of influenza viruses that cause severe outcomes of the disease. In this paper, we analyzed the evolution, antigenic and genetic drift of Mexican isolates from 2009, at the beginning of the pandemic, to 2014. We found a clear variation of the virus in Mexico from the 2011-2014 season due to different markers and in accordance with previous reports. In this study, we identified 13 novel substitutions with important biological effects, including virulence, T cell epitope presented by MHC and host specificity shift and some others substitutions might have more than one biological function. The systematic monitoring of mutations on whole genome of influenza A pH1N1 (2009) virus circulating at INER in Mexico City might provide valuable information to predict the emergence of new pathogenic influenza virus.

Indexed as

SeasonsAmino Acid SubstitutionAntigens, ViralDemographyFemaleGenome, ViralHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H1N1 SubtypeInfluenza, HumanLikelihood FunctionsMaleMexicoMiddle AgedPhylogenyPrevalenceAntigens, ViralHemagglutinin Glycoproteins, Influenza Virus

Identifiers

PMID28692701
PMCPMC5503254
OpenAlexW2734390160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.